Stocks
Evolent Health (EVH) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 6.13% | 3.24% | -1.26% | 3.32% | -19.3% | 5.42% | ||
| Changes by years, y/y, % | +32pp | -3pp | -4pp | +5pp | -23pp | -5.9% | |||
Evolent Health. EBITDA margin, %
Evolent Health. EBITDA margin, changes, pp
Evolent Health (EVH) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | 3.44% | 4.86% | -78.2% | 2.75% | 1.96% | 5.42% | |
| Changes by years, y/y, % | -2pp | +3pp | -80pp | +9pp | -1pp | |||
| Changes by quarters, q/q, % | +9pp | +1pp | -83pp | +81pp | -1pp | |||
